Vutrisiran is a subcutaneously administered, small interfering RNA (siRNA) therapeutic that targets and degrades transthyretin (TTR) mRNA to treat transthyretin-mediated amyloidosis.
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea